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The Recognition of Active Retrolental Fibroplasia
R. Michael Nisbet, MD*

As the incidence of retrolental fibroplasia increases, physicians must become familiar with its appearance. This
report describes the examination techniques and morphology of the active and regressive stages of retrolental fibroplasia.

gms (4.2 Ib) or a gestational age under 34 weeks should be
screened if they received oxygen in concentrations greater
than room air.
Because ophthalmoscopic monitoring of vasospasm is inaccurate and early examination is impeded by vitreous
haze and embryologic vascular remnants (Fig. 1), the best
time to perform the examination is just before the infant is
discharged from the nursery.

After retrolental fibroplasia (RLF) was described by Terry
in 1942 (1), it rapidly became the single largest cause of
infant blindness in the United States. A national cooperative study (2) designed to seek causes demonstrated that the
length of time the premature infant is kept in an oxygenenriched environment is an important factor in causing
RLF As a result, the use of oxygen for premature infants was
severely curtailed for several years.

Examination Techniques
The ocular fundus cannot be examined properly unless the
pupil is dilated. Tropicamide {V2%) and phenylephrine
(2.5%) are instilled in the conjunctival cul-de-sac 30 minutes and again 15 minutes before the examination takes
place. Tropicamide relaxes the iris sphincter and phenylephrine stimulates the dilator muscle to produce maximal dilatation. Systemic absorption of tropicamide may
produce lethargy or apnea. Phenylephrine may make the
eyelid skin blanch, but it causes no adverse effects.

In the ensuing years, however, pediatricians tended to use
oxygen more liberally to manage idiopathic respiratory
distress syndrome, and the incidence of RLF increased (3).
Consequently, ophthalmologists are now often called upon
to screen premature infants.

The binocular indirect ophthalmoscope is indispensable
for viewing the retinal periphery. A wider view is obtained
ifa 2X condensing lens with a diameter less than 2.5 cm is
used. Examination with this instrument may be combined
with scleral depression to evaluate the retina as far anterior
as the ora serrata.

Infant Screening
The infant at greatest risk of developing RLF is one with a
birth weight of less than 1500 gms (3.3 Ib) who suffers from
the respiratory distress syndrome with multiple episodes of
apnea (3). All infants with a birth weight of less than 2000

The child may be examined within the Isolette if its body
temperature is difficult to maintain (Fig. 2). Otherwise, the
examination should be performed outside for better visualization. The infant will be more docile if examined soon
after feeding. Its eyelids may be held apart with the fingers
or a Sauer infant eyelid speculum (Fig. 3). If the speculum
is used, the child's cornea must be kept moist with artificial
tears.

Submitted for publication: October 12, 1979
Accepted for publication: December 14, 1979
* Formerly, Department of Ophthalmology, Henry Ford Hospital; presently. Associate Professor, Department of Ophthalmology, The University of Texas Medical Branch, Galveston, Texas

If active disease is found, photographic documentation is
helpful. Fluorescein angiography is a valuable research
tool but is not used routinely. Both fundus photography and
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Fig. 1
Persistent Tunica Vasculosa Lentis.

Fig. 3
Eyelids retracted with infant speculum.

fluorescein angiography are made easier by the pediatric
photography platform designed to be used with the Zeiss
fundus camera (4) (Fig. 4).

Recognition of Active Disease
The earliest definite clinical sign of RLF is tortuosity and
dilatation o f t h e vessels near the disc (Fig. 5), caused by
increased blood flow to the abnormal vascular channels in
the peripheral retina. The arteriovenous shunt, which develops at the junction of vascularized and avascular retina,
is the most prominent structure in the fundus of the eye
affected by RLF and is an important landmark to identify
(Fig. 6). Neovascularization occurs near this structure, and
normal vascularization begins here during the regressive
stages. In full-term infants, the temporal periphery of the
retina is normally not vascularized until after birth, so it is
not surprising that in premature infants a wide avascular
zone is present temporally. However, avascularity alone
does not imply the presence of active RLF.
The major criterion for the diagnosis is a prominent demarcation line betwen vascular and avascular retina, with
evidence of abnormal vascularization at that junction. Preretinal proliferative neovascularization develops immediately posterior to the arteriovenous shunt and is usually
associated with areas of capillary nonprofusion (Fig. 7). It

Fig. 2
Examination through clear dome of Isolette.
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Fig. 4

Fig. 5
Posterior pole of eye w i t h active retrolental fibroplasia.

Pediatric photography platform attached to Zeiss fundus camera.

Fig. 6
Prominent arteriovenous shunt in temporal periphery w i t h inserting retinal vessels.
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Fig. 8
Enlarged neovascular frond with hemorrhage along arteriovenous shunt.

looks like other peripheral proliferative retinopathies, especially those associated with the sickling hemoglobinopathies.
As the active phase develops into a more advanced stage,
the neovascular fronds enlarge, hemorrhage appears near
the fronds, in the vitreous and along the arteriovenous
shunt, and the avascular retina may be thickened and
elevated (Fig. 8).
It is important to recognize the early signs of regression of
the active disease. O'Grady (5) first suggested that the
beginning o f t h e regression process may be signaled by a
double demarcation line composed of the original arteriovenous shunt and a fine brush border of normal retinal
vasculature. As vascularization becomes normal, the shunt
is left behind and atrophies. Remnants may remain as a
sentinel of the disease process (Fig. 9).

Fig. 7
Preretinal proliferative neovascularization (top); fluorescein angiography shows avascular retina, neovascularization, and capillary nonperfusion (bottom).

The role of the ophthalmologist is to advise physicians and
parents of premature infants. Knowledge of the natural
history of the disease process and recognition of its stages
are paramount to accomplishing that goal.
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Fig. 9
A. Temporal periphery at age 10 weeks shows double demarcation line; B. Fluorescein angiogram shows fine brush border of normal
retinal vessels; C . At 13 weeks, vessel growth has continued and shunt atrophy begins; D. At 16 weeks, only a gray remnant of the
arteriovenous shunt remains.
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